Montreal Neurological Institute and Hospital North Wing Expansion
Research Renewed / Improving Lives
Research Renewed / Improving Lives
Today the Montreal Neurological Institute of McGill University launched its largest campaign in 73 years of history. Securing the funds to complete the new North Wing is a central priority of the MNI’s ‘Thinking Ahead’ Campaign, a five-year $40 million initiative to invest in people and expand facilities and services at the MNI. The new 75,000 sq. ft. pavilion will provide much-needed space for research activities and clinical care. The building is funded in part by a $35 million grant from the Canadian and Quebec governments, as part of the Canada Foundation for Innovation (CFI) program to the Montreal Consortium for Brain Imaging Research (MCBIR).
The MNI’s McConnell Brain Imaging Centre, currently one of the top three neuroimaging centres in the world, will be at the heart of the North Wing as the home to the MCBIR project. The MNI will house cutting-edge brain imaging facilities including Positron Emission Tomography (PET), Magnetic Resonance Imaging (MRI), functional MRI (fMRI), and a Magneto-Encephalograph (MEG), supported by a supercomputer and advanced informatics facilities. Once completed and fully equipped, the scientific community focused on brain research at the MNI and McGill will be without equivalent anywhere in the world.
“This expansion will create a significant and unique resource for researchers, advancing our understanding of brain diseases, addiction and treatment strategies,” says Dr. Alan Evans, principal investigator of the MCBIR and researcher at the MNI. “We have the capacity to build in Montreal a global database of brain imaging information that we can pass on to the world’s community.”
New laboratories in imaging, experimental therapeutics and other specialties will provide research facilities and equipment for principal investigators and their teams. These new facilities will assist the MNI in attracting the brightest and most talented scientists from around the world.
The new North Wing will contain a major expansion of vital clinical space for the MNI’s existing polyclinic facilities, which integrate comprehensive patient care with innovative research. A new comprehensive outpatient diagnostic and treatment centre, equipped with modern, enhanced clinical and research facilities, will offer the most efficient and effective personal care in a comfortable and caring environment, as well as support the development of new treatment options for neurological diseases through the adjacency of the Clinical Research Unit.
Patients, staff and visitors will benefit from a new improved ambulatory entrance and new access from University Street, named in honour of the Cyril & Dorothy and Joel & Jill Reitman Family Foundation, in addition to the Manulife Financial Atrium, a courtyard containing a Healing Garden.
About the MNI
The Montreal Neurological Institute is a McGill University research and teaching institute, dedicated to the study of the nervous system and neurological diseases. Founded in 1934 by the renowned Dr. Wilder Penfield, the MNI is one of the world’s largest institutes of its kind. MNI researchers are world leaders in cellular and molecular neuroscience, brain imaging, cognitive neuroscience and the study and treatment of epilepsy, multiple sclerosis and neuromuscular disorders. The MNI, with its clinical partner, the Montreal Neurological Hospital (MNH), part of the McGill University Health Centre, continues to integrate research, patient care and training, and is recognized as one of the premier neuroscience centres in the world. At the MNI, we believe in investing in the faculty, staff and students who conduct outstanding research, provide advanced, compassionate care of patients and who pave the way for the next generation of medical advances. Highly talented, motivated people are the engine that drives research – the key to progress in medical care.
About the Montreal Consortium for Brain Imaging Research (MCBIR)
MCBIR unites researchers and health care professionals from the MNI, the Douglas Mental Health University Institute, the Lady Davis Institute, and the Instituts de Réadaptation in Québec City and Montreal, McGill University, Université de Montréal, Université Laval, Université du Québec à Chicoutimi and Concordia University. A crucial aspect of the Consortium is the integration of people from very different disciplines. Basic neuroscientists and clinical researchers in psychiatry and neurology are brought together with engineers, mathematicians and computer scientists. This has been the successful model at the MNI and this principle will be extended to involve social scientists and clinicians working with at-risk populations in the community. Researchers hope to combine genetic information with imaging and behavioural data in order to gain insights into how gene modifications affect the brain and behaviour.